# Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)

> **NCT04413994** · NA · RECRUITING · sponsor: **Prolacta Bioscience** · enrollment: 200 (estimated)

## Conditions studied

- Prematurity
- Vascular Aging

## Interventions

- **DIETARY_SUPPLEMENT:** Humavant

## Key facts

- **NCT ID:** NCT04413994
- **Lead sponsor:** Prolacta Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-09
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-08-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04413994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04413994, "Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04413994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*